Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia: A Multicenter, Randomized, Double-blind, Placebo-controlled Study With a Long-term Open-label Extension

NCT04119050 is registered in ClinicalTrials.gov with Janssen Research & Development, LLC as lead sponsor.

NCT NCT04119050
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04119050 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia: A Multicenter, Randomized, Double-blind, Placebo-controlled Study With a Long-term Open-label Extension
Lead sponsor
Janssen Research & Development, LLC
Phase
Phase 2/3
Overall status
Active, not recruiting
Start date
August 15, 2019
Completion date
April 1, 2028
Enrollment
118 (actual)
Sites
171

Conditions

As the registry lists them; a condition with its own page is linked.

warm autoimmune hemolytic anemia